Knowing that your 20-unit injection contains 1.6 mg helps you understand how your dose compares to published clinical trial data, where most patients achieved significant weight loss at doses ranging from 1.0 to 2.4 mg per week
10.1016/j.jaut.2017.04.006 117 RameshS.ArachchigeA
In recent years, several options have emerged, providing patients with additional choices beyond traditional methods
GLP-1 agonist medications Ozempic, Wegovy, and others also are delivering dramatic results for millions
Retatrutide is best known for one number: the 24.2% average body weight loss recorded in its 48-week phase 2 obesity trial
Preclinical data showed that LX9851 significantly reduced body weight, food intake, and fat mass in obese mice, and further enhanced weight loss when combined with semaglutide, effectively preventing weight rebound after GLP-1 treatment